SCHEMBL6093754

SCHEMBL6093754

CN1CCN(C=CC(=O)c2cc(N)ccc2O)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.44
KDM4E B2RXH2 2/20 0.44
MEN1 O00255 1/20 0.44
TNF P01375 1/20 0.44
CYP3A4 P08684 1/20 0.44
HSPD1 P10809 1/20 0.44
THRB P10828 1/20 0.44
CYP2C9 P11712 1/20 0.44
HPGD P15428 1/20 0.44
ALOX15 P16050 1/20 0.44
CASP1 P29466 1/20 0.44
CYP2C19 P33261 1/20 0.44
PTGS2 P35354 1/20 0.44
KDR P35968 1/20 0.44
BRCA1 P38398 1/20 0.44
RECQL P46063 1/20 0.44
CASP7 P55210 1/20 0.44
HSPE1 P61604 1/20 0.44
KMT2A Q03164 1/20 0.44
HIF1A Q16665 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6094576 0.99 KDM4E (0.43) ALDH1A1KDM4EMEN1TNFCYP3A4
SCHEMBL6094562 0.89 KDM4E (0.49) ALDH1A1KDM4EMEN1TNFCYP3A4
Hydrochloric Acid SCHEMBL6095852 0.87 MEN1 (0.47) ALDH1A1KDM4EMEN1TNFCYP3A4
SCHEMBL6094789 0.84 MAPT (0.51) ALDH1A1KDM4EMEN1TNFCYP3A4
Hydrochloric Acid SCHEMBL6093512 0.83 MAPT (0.50) ALDH1A1KDM4EMEN1TNFCYP3A4
SCHEMBL6098465 0.83 KDM4E (0.43) ALDH1A1KDM4EMEN1TNFCYP3A4
Hydrochloric Acid SCHEMBL6094966 0.82 KDM4E (0.42) ALDH1A1KDM4EMEN1TNFCYP3A4
SCHEMBL6097293 0.78 APP (0.38) ALDH1A1KDM4EMEN1CYP3A4THRB
SCHEMBL6093384 0.77 KDM4E (0.40) ALDH1A1KDM4EMEN1TNFCYP3A4
Hydrochloric Acid SCHEMBL6092945 0.76 KDM4E (0.39) ALDH1A1KDM4EMEN1TNFCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7070626-B2 (P-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds WELLA AG (DE) 2006-07-04 US disclosed
EP-1286953-B1 (P-AMINO-HYDROXYPHENYL)-ACRYLAMIDE DERIVATIVES AND DYES CONTAINING SAID COMPOUNDS WELLA AG (DE) 2004-02-18 EP disclosed
US-20030192132-A1 (P-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds HFC PRESTIGE INTERNATIONAL HOLDING SWITZERLAND S.A.R.L (CH) 2003-10-16 US disclosed
EP-1286953-A1 (P-AMINO-HYDROXYPHENYL)-ACRYLAMIDE DERIVATIVES AND DYES CONTAINING SAID COMPOUNDS Wella Aktiengesellschaft (DE) 2003-03-05 EP disclosed
WO-2002079144-A1 (P-AMINO-HYDROXYPHENYL)-ACRYLAMIDE DERIVATIVES AND DYES CONTAINING SAID COMPOUNDS WELLA AKTIENGESELLSCHAFT (DE) 2002-10-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030192132-A1 (P-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds KRT18, ALDH7A1, IK ALDH1A1 36/4885KDM4E 3412/4885MEN1 4771/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.